Atrion Corporation

409.70+1.65+0.40%Vol 11.00K1Y Perf -28.91%
Oct 3rd, 2023 16:00 DELAYED
BID375.88 ASK441.24
Open419.54 Previous Close408.05
Pre-Market- After-Market409.70
 - -  - -%
Target Price
300.00 
Analyst Rating
— 0.00
Potential %
-26.78 
Finscreener Ranking
★★★★+     57.27
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★★★+     59.26
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★★★+     60.65
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
★★★+     48.48
Price Range Ratio 52W %
3.39 
Earnings Rating
Buy
Market Cap720.93M 
Earnings Date
14th Nov 2023
Alpha-0.01 Standard Deviation0.08
Beta0.51 

Today's Price Range

405.73433.15

52W Range

399.30705.74

5 Year PE Ratio Range

26.2051.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
1.71%
1 Month
-13.18%
3 Months
-28.13%
6 Months
-36.03%
1 Year
-28.91%
3 Years
-32.35%
5 Years
-39.11%
10 Years
63.26%

TickerPriceChg.Chg.%
ATRI409.701.65000.40
AAPL172.40-1.3500-0.78
GOOG133.30-1.8700-1.38
MSFT313.39-8.4100-2.61
XOM115.830.20000.17
WFC38.67-0.9400-2.37
JNJ155.340.19000.12
FB196.640.99000.51
GE107.76-1.0300-0.95
JPM142.71-1.0600-0.74
ProfitabilityValueIndustryS&P 500US Markets
41.50
21.40
29.00
26.40
18.97
RevenueValueIndustryS&P 500US Markets
140.65M
79.35
2.29
2.20
DividendsValueIndustryS&P 500US Markets
1.46
8.60
11.38
12.60
Payout ratio40.00
Earnings HistoryEstimateReportedSurprise %
Q01 2024-3.73-
Q01 2023-1.98-
Q04 2022-4.70-
Q03 2022-4.94-
Q02 2022-5.20-
Q01 2022-4.71-
Q04 2021-4.50-
Q03 2021-4.58-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date14th Nov 2023
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume11.00K
Shares Outstanding1.76K
Shares Float1.36M
Trades Count934
Dollar Volume4.61M
Avg. Volume4.19K
Avg. Weekly Volume5.29K
Avg. Monthly Volume4.05K
Avg. Quarterly Volume3.24K

Atrion Corporation (NASDAQ: ATRI) stock closed at 408.05 per share at the end of the most recent trading day (a -1.24% change compared to the prior day closing price) with a volume of 2.45K shares and market capitalization of 720.66M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 616 people. Atrion Corporation CEO is David A. Battat.

The one-year performance of Atrion Corporation stock is -28.91%, while year-to-date (YTD) performance is -27.06%. ATRI stock has a five-year performance of -39.11%. Its 52-week range is between 399.3 and 705.74, which gives ATRI stock a 52-week price range ratio of 3.39%

Atrion Corporation currently has a PE ratio of 30.00, a price-to-book (PB) ratio of 4.17, a price-to-sale (PS) ratio of 7.44, a price to cashflow ratio of 26.80, a PEG ratio of -, a ROA of 13.93%, a ROC of 14.06% and a ROE of 15.51%. The company’s profit margin is 18.97%, its EBITDA margin is 29.00%, and its revenue ttm is $140.65 Million , which makes it $79.35 revenue per share.

Of the last four earnings reports from Atrion Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Atrion Corporation’s next earnings report date is 14th Nov 2023.

The consensus rating of Wall Street analysts for Atrion Corporation is (0), with a target price of $300, which is -26.78% compared to the current price. The earnings rating for Atrion Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Atrion Corporation has a dividend yield of 1.46% with a dividend per share of $8.60 and a payout ratio of 40.00%.

Atrion Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 8.23, ATR14 : 12.77, CCI20 : -105.67, Chaikin Money Flow : -0.07, MACD : -20.13, Money Flow Index : 44.16, ROC : -9.44, RSI : 32.38, STOCH (14,3) : 12.36, STOCH RSI : 0.66, UO : 39.67, Williams %R : -87.64), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Atrion Corporation in the last 12-months were: Athey Preston (Buy at a value of $104 670), Battat David A (Option Exercise at a value of $0), BATTAT EMILE A (Option Exercise at a value of $0), Jeffery Strickland (Option Excercise at a value of $0), Jeffery Strickland (Sold 1 000 shares of value $675 000 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
1 (100.00 %)
Summary Rating-
0.00
-
0.00
Strong Sell
5.00

Atrion Corporation

Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.

CEO: David A. Battat

Telephone: +1 972 390-9800

Address: One Allentown Parkway, Allen 75002, TX, US

Number of employees: 616

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

61%39%

Bearish Bullish

59%41%

Bearish Bullish

56%44%

 

News

Stocktwits